BioSig Technologies, Inc. (BSGM) financial statements (2023 and earlier)

Company profile

Business Address 55 GREENS FARMS ROAD
WESTPORT, CT 06880
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,70017,53515,50422,47528,26832,74836,927
Cash and cash equivalents11,70017,53515,50422,47528,26832,74836,927
Receivables 100199    
Inventory, net of allowances, customer advances and progress billings1,8811,881731650768806800
Inventory1,8811,881731650768806800
Prepaid expense354433515209301338454
Other current assets 433515209301  
Other undisclosed current assets(41)(383)(515)(209)(301) 471
Total current assets:13,89419,99916,94923,33429,33733,89338,652
Noncurrent Assets
Operating lease, right-of-use asset604693252356306410513
Property, plant and equipment652557388381289188175
Intangible assets, net (including goodwill)327332337342347351356
Intangible assets, net (excluding goodwill)327332337342347351356
Prepaid expense   151014
Deposits noncurrent assets4292101102102102102
Other noncurrent assets 424438    
Other undisclosed noncurrent assets (424)(438)(0)0  
Total noncurrent assets:1,6251,6741,0781,1821,0491,0611,160
TOTAL ASSETS:15,51921,67318,02724,51630,38634,95339,812
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,1792,1693,0273,459   
Accrued liabilities243280332312   
Employee-related liabilities552499515448   
Interest and dividends payable82797775   
Settlement liabilities6131,0001313   
Other undisclosed accounts payable and accrued liabilities6893112,0902,610   
Deferred revenue32323232   
Due to related parties86808014731715598
Other undisclosed current liabilities2792902442584,7914,8053,509
Total current liabilities:2,5762,5713,3833,8965,1084,9603,607
Noncurrent Liabilities
Long-term debt and lease obligation37340912812289
Operating lease, liability37340912812289
Liabilities, other than long-term debt5132129   
Deferred revenue5132129   
Other undisclosed noncurrent liabilities   (1)5,1084,9373,518
Total noncurrent liabilities:37842222575,1094,9823,695
Other undisclosed liabilities    (5,108)(4,960)(3,607)
Total liabilities:2,9542,9933,4053,9535,1094,9823,695
Temporary equity, carrying amount105105105105105105105
Stockholders' equity
Stockholders' equity attributable to parent12,24118,13714,14319,87624,37028,54633,218
Common stock36353232313029
Additional paid in capital201,127198,380187,136185,168181,344175,228168,499
Accumulated deficit(188,922)(180,278)(173,025)(165,324)(157,005)(146,712)(135,311)
Stockholders' equity attributable to noncontrolling interest2194383745828021,3202,794
Other undisclosed stockholders' equity   (0)(0)  
Total stockholders' equity:12,46018,57514,51720,45825,17229,86636,012
TOTAL LIABILITIES AND EQUITY:15,51921,67318,02724,51630,38634,95339,812

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues8108207118   
Cost of revenue (38)(62)(99)   
Gross profit:87014519   
Operating expenses(9,007)(7,871)(8,196)(8,579)(10,932)(13,100)(22,349)
Other undisclosed operating loss   (1)(0)  
Operating loss:(8,999)(7,801)(8,051)(8,560)(10,932)(13,100)(22,349)
Nonoperating income (expense) 1  (44)22
Investment income, nonoperating    (44)22
Other nonoperating income 1     
Interest and debt expense 553     
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(2)  144  
Loss from continuing operations before equity method investments, income taxes:(9,001)(7,247)(8,051)(8,559)(10,932)(13,098)(22,346)
Other undisclosed income from continuing operations before income taxes2      
Loss from continuing operations before income taxes:(8,999)(7,247)(8,051)(8,559)(10,932)(13,098)(22,346)
Other undisclosed income (loss) from continuing operations555(554) (0)(0)(2)(2)
Loss before gain (loss) on sale of properties:(8,444)(7,801)(8,051)(8,559)(10,932)(13,100)(22,349)
Other undisclosed net income (loss)(555)554 0022
Net loss:(8,999)(7,247)(8,051)(8,559)(10,932)(13,098)(22,346)
Net income (loss) attributable to noncontrolling interest355(6)3502396391,6973,158
Other undisclosed net income attributable to parent   10  
Net loss attributable to parent:(8,644)(7,253)(7,701)(8,319)(10,292)(11,402)(19,188)
Other undisclosed net loss available to common stockholders, basic(2)(2)(3)(2)(2)(2)(5)
Net loss available to common stockholders, diluted:(8,646)(7,255)(7,704)(8,321)(10,295)(11,404)(19,193)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(8,999)(7,247)(8,051)(8,559)(10,932)(13,098)(22,346)
Comprehensive loss:(8,999)(7,247)(8,051)(8,559)(10,932)(13,098)(22,346)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest355(6)3502396391,6973,158
Comprehensive loss, net of tax, attributable to parent:(8,644)(7,253)(7,701)(8,320)(10,293)(11,402)(19,188)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: